NATERA, INC. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
NATERA, INC. (NTRA) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 292.00 thousand shares for the 12-month period ending 2017-12-31, per its 10-K filed 2020-03-02.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2020-03-02
- NATERA, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2017-03-31 was 285.00K shares.
- NATERA, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2017 was 292.00K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|
| 2017-12-31 | 292.00K shares 10-K · filed 2020-03-02 | |
| 2017-03-31 | 285.00K shares 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |